1. Home
  2. EHC vs PEN Comparison

EHC vs PEN Comparison

Compare EHC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

SELL

Current Price

$127.76

Market Cap

11.2B

Sector

Health Care

ML Signal

SELL

Logo Penumbra Inc.

PEN

Penumbra Inc.

SELL

Current Price

$321.04

Market Cap

12.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EHC
PEN
Founded
1983
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
12.6B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
EHC
PEN
Price
$127.76
$321.04
Analyst Decision
Strong Buy
Hold
Analyst Count
13
17
Target Price
$148.17
★ $362.54
AVG Volume (30 Days)
★ 880.8K
357.4K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 0.66%
N/A
EPS Growth
24.22
★ 1155.56
EPS
★ 3.47
1.70
Revenue
N/A
★ $1,403,665,000.00
Revenue This Year
$8.84
$13.46
Revenue Next Year
$8.26
$13.01
P/E Ratio
★ $36.90
$189.07
Revenue Growth
N/A
★ 17.50
52 Week Low
$92.77
$221.26
52 Week High
$129.96
$362.41

Technical Indicators

Market Signals
Indicator
EHC
PEN
Relative Strength Index (RSI) 64.54 55.76
Support Level $118.99 $315.42
Resistance Level N/A $324.05
Average True Range (ATR) 2.66 1.80
MACD 0.50 0.54
Stochastic Oscillator 78.56 77.35

Price Performance

Historical Comparison
EHC
PEN

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: